Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Mar 27, 2024; 16(3): 759-767
Published online Mar 27, 2024. doi: 10.4240/wjgs.v16.i3.759
Table 1 Patient general information
Indicators
Control group (n = 45)
Research group (n = 50)
χ2/t value
P value
Age (yr)56.51 ± 5.9856.16 ± 6.540.2710.787
Sex (male/female)25/2027/230.0230.879
BMI (kg/m2)22.67 ± 2.7922.80 ± 2.630.2340.816
Stone diameter (cm)1.55 ± 0.421.49 ± 0.630.5400.591
Number of stones (n)2.24 ± 0.572.16 ± 0.680.6180.538
Total bilirubin (μmol/L)34.94 ± 16.1132.14 ± 16.300.8410.403
Table 2 Efficacy of the two treatments, n (%)
Indicators
Control group (n = 45)
Research group (n = 50)
χ2 value
P value
Marked effectiveness22 (48.89)30 (60.00)
Improvement13 (28.89)17 (34.00)
Ineffectiveness10 (22.22)3 (6.00)
Total effective rate35 (77.78)47 (94.00)5.2770.022
Table 3 Safety of the two groups, n (%)
Indicators
Control group (n = 45)
Research group (n = 50)
χ2 value
P value
Incision infection3 (6.67)1 (2.00)
Biliary fistula1 (2.22)0 (0.00)
Lung infection3 (6.67)1 (2.00)
Hemobilia2 (4.44)0 (0.00)
Total9 (20.00)2 (4.00)5.9220.015